International Biotechnology (LON:IBT) Shares Cross Above 200 Day Moving Average – Here’s What Happened

International Biotechnology (LON:IBT) crossed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of GBX 946.83 and traded as high as GBX 960. International Biotechnology shares last traded at GBX 956, with a volume of 62,941 shares changing hands.

International Biotechnology Stock Up 0.8%

The stock’s 50 day simple moving average is GBX 969.14 and its two-hundred day simple moving average is GBX 946.83. The firm has a market cap of £304.28 million, a P/E ratio of 3.95 and a beta of 0.52. The company has a debt-to-equity ratio of 9.43, a current ratio of 0.11 and a quick ratio of 0.32.

International Biotechnology (LON:IBT) last announced its quarterly earnings results on Tuesday, May 12th. The company reported GBX (4.83) earnings per share (EPS) for the quarter. International Biotechnology had a return on equity of 27.35% and a net margin of 82.27%.The firm had revenue of GBX 24 million for the quarter. As a group, research analysts forecast that International Biotechnology will post 0.9435943 earnings per share for the current year.

About International Biotechnology

The Company’s investment objective is to achieve long-term capital growth by investing in biotechnology and other life sciences companies.

The Company will seek to achieve its objective by investing in a diversified portfolio of companies which may be quoted or unquoted and whose shares are considered to have good growth prospects, with experienced management and strong potential upside through the development and/or commercialisation of a product, device or enabling technology. Investments may also be made in related sectors such as medical devices and healthcare services.